J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seman, A. L.
Right arrow Articles by Murphey-Corb, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seman, A. L.
Right arrow Articles by Murphey-Corb, M.
Agricola
Right arrow Articles by Seman, A. L.
Right arrow Articles by Murphey-Corb, M.
Journal of General Virology (2000), 81, 2441-2449.
© 2000 Society for General Microbiology


Animal: RNA Viruses

The replicative capacity of rhesus macaque peripheral blood mononuclear cells for simian immunodeficiency virus in vitro is predictive of the rate of progression to AIDS in vivo

Amy L. Seman1, William F. Pewen1, Lynn F. Fresh2, Louis N. Martin2 and Michael Murphey-Corb1

Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Room E1240 Biomedical Science Tower, Pittsburgh, PA 15261, USA1
Tulane Regional Primate Research Center, 18703 Three Rivers Road, Covington, LA 70433, USA2

Author for correspondence: Michael Murphey-Corb. Fax +1 412 648 1448. e-mail mcorb{at}pitt.edu

Survival of rhesus macaques (Macaca mulatta) experimentally infected with simian immunodeficiency virus (SIV) varies significantly from animal to animal. Some animals die within 2 months while others survive for more than 5 years, even when identical inocula are used. This diversity in survival creates a significant problem in the design of therapeutic and vaccine trials using the SIV–macaque model because the use of small numbers of animals may provide results that are misleading. Identifying an in vitro assay that could determine the survival of monkeys prior to infection would prove extremely useful for stratifying experimental groups. Analysis of the survival of a cohort of 59 control animals obtained from over a decade of vaccine and therapeutic trials has demonstrated that the ability of peripheral blood mononuclear cells (PBMC) from a naïve animal to produce virus in vitro was highly predictive of disease progression in vivo following experimental inoculation. Animals classified in vitro as high producers of virus progressed to disease significantly more rapidly than animals classified as either low (P=0·002) or intermediate (P=0·013) producers of virus. The hierarchy of high and low virus production was maintained in purified CD4+ T cell cultures, indicating that this phenotype is an intrinsic property of the CD4+ T cell itself. These findings should significantly aid in the design of vaccine and therapeutic trials using the SIV–macaque model. Furthermore, since these studies suggest that the rate of virus replication is controlled by innate characteristics of the individual, they provide new insight into the pathogenesis of AIDS.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
S. Venneti, D. Bonneh-Barkay, B. J. Lopresti, S. J. Bissel, G. Wang, C. A. Mathis, M. Piatak Jr., J. D. Lifson, J. O. Nyaundi, M. Murphey-Corb, et al.
Longitudinal in Vivo Positron Emission Tomography Imaging of Infected and Activated Brain Macrophages in a Macaque Model of Human Immunodeficiency Virus Encephalitis Correlates with Central and Peripheral Markers of Encephalitis and Areas of Synaptic Degeneration
Am. J. Pathol., June 1, 2008; 172(6): 1603 - 1616.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. J. Bissel, G. Wang, D. Bonneh-Barkay, A. Starkey, A. M. Trichel, M. Murphey-Corb, and C. A. Wiley
Systemic and Brain Macrophage Infections in Relation to the Development of Simian Immunodeficiency Virus Encephalitis
J. Virol., May 15, 2008; 82(10): 5031 - 5042.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. N. Brown, A. Trichel, and S. M. Barratt-Boyes
Parallel Loss of Myeloid and Plasmacytoid Dendritic Cells from Blood and Lymphoid Tissue in Simian AIDS
J. Immunol., June 1, 2007; 178(11): 6958 - 6967.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. J. Bissel, G. Wang, A. M. Trichel, M. Murphey-Corb, and C. A. Wiley
Longitudinal Analysis of Monocyte/Macrophage Infection in Simian Immunodeficiency Virus-Infected, CD8+ T-Cell-Depleted Macaques that Develop Lentiviral Encephalitis
Am. J. Pathol., May 1, 2006; 168(5): 1553 - 1569.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. Peng, R. Voltan, L. Lim, Y. Edghill-Smith, S. Phogat, D. S. Dimitrov, K. Arora, M. Leno, S. Than, R. Woodward, et al.
Rhesus Macaque Resistance to Mucosal Simian Immunodeficiency Virus Infection Is Associated with a Postentry Block in Viral Replication
J. Virol., May 13, 2002; 76(12): 6016 - 6026.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. H. Fuller, P. A. Rajakumar, L. A. Wilson, A. M. Trichel, J. T. Fuller, T. Shipley, M. S. Wu, K. Weis, C. R. Rinaldo, J. R. Haynes, et al.
Induction of Mucosal Protection against Primary, Heterologous Simian Immunodeficiency Virus by a DNA Vaccine
J. Virol., March 7, 2002; 76(7): 3309 - 3317.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Guan, J. B. Whitney, C. Liang, and M. A. Wainberg
Novel, Live Attenuated Simian Immunodeficiency Virus Constructs Containing Major Deletions in Leader RNA Sequences
J. Virol., March 15, 2001; 75(6): 2776 - 2785.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2000 by the Society for General Microbiology.